Endometrial Cancer Trial, Recruiting NCT03438474 Sponsor: Philipps University Marburg Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT03438474
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with uterine (endometrial) cancer that has been confirmed by a tissue sample, and your cancer is at a specific stage or type as determined by your doctor (confirm with trial site for your exact stage and type)
  • You have either not yet had surgery for your uterine cancer, OR you had a hysterectomy (removal of the uterus) within the last 8 weeks without removal of lymph nodes
  • Your lymph nodes are not significantly enlarged
  • You are generally able to carry out daily activities with little to no limitation (your doctor will assess this)
  • You are between 18 and 75 years old
  • You are willing and able to give written consent to participate
  • You are able to follow the trial requirements reliably

Who may not be able to join:

  • Your cancer is at a very early stage with a low-grade (slow-growing) tumour of a specific common type
  • You have a type of uterine cancer called a sarcoma (except for a specific type called carcinosarcoma)
  • Your cancer has spread significantly to other parts of the body (advanced stage III or IV), except for very small amounts of cancer found in lymph nodes
  • There are visible signs that the cancer has spread outside the uterus
  • Your cancer has come back after previous treatment
  • You have already received chemotherapy, radiotherapy, or hormone therapy for your uterine cancer
  • You have another health condition that would make surgery or chemotherapy unsafe for you
  • Your medical history suggests you may be at high risk during surgery
  • You are currently taking medications that could increase surgical risks, such as blood thinners
  • You have a condition or situation that would make it difficult for you to participate fully or attend follow-up appointments
  • You have a second (other) cancer where that cancer or its treatment could affect your outlook
  • You have a known HIV infection or AIDS
  • You are already taking part in another clinical trial, unless specifically approved by the trial organisers

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Philipp Harter, Professor MD, Kliniken Essen Mitte, Gynäkologie und gynäkologische Onkologie

Phone: +49 (0) 201 174-34511

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Philipps University Marburg
Registry
ClinicalTrials.gov
Start date
28 March 2018
Est. completion
15 February 2028

Where this trial is recruiting

🇩🇪 Germany 🇯🇵 Japan 🇰🇷 South Korea

Primary endpoints

Overall survival (OS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov